| Trial | Intervention | No. participants | Median (h) | Range (h) | 95% CI | P‐value |
| Llanos‐Cuentas 2001 | Atovaquone‐proguanil | 14 | 46 | 8 to 92 | — | — |
| Chloroquine | 13 | 48 | 20 to 72 | — | — | |
| Borrmann 2003 | Atovaquone‐proguanil | 92 | 47 | 48 (IQR) | — | 0.85 |
| Amodiaquine | 78 | 46 | 43 (IQR) | — | — | |
| Llanos‐Cuentas 2001 | Atovaquone‐proguanil | 5 | 40 | 20 to 26 | — | — |
| Sulfadoxine‐pyrimethamine | 7 | 44 | 28 to 72 | — | — | |
| Mulenga 1999 | Atovaquone‐proguanil | 67 | 23 | 1 to 160.5 | — | — |
| Sulfadoxine‐pyrimethamine | 77 | 48 | 6 to 101 | — | — | |
| Anabwani 1999 | Atovaquone‐proguanil | 81 | 29.8 | 0.5 to 99 | ‐11 to 6.4 | 0.60 |
| Halofantrine | 83 | 35.3 | 0.5 to 123 | — | — | |
| Looareesuwan 1999a | Atovaquone‐proguanil | 84 | 53.5 | 3 to 152 | — | — |
| Mefloquine | 88 | 50.0 | 4 to 147 | — | — |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.